Treatment Information

Back

Lung Cancer treatment details. Chemotherapy.

Aomori Prefectural Central Hospital, Aomori, Japan.

Survival: monthsCountry:Japan
Toxiciy Grade:4City/State/Province:Aomori
Treatments:ChemotherapyHospital:Aomori Prefectural Central Hospital
Drugs:Journal:Link
Date:May 2014

Description:

Patients:
This phase 2 study involved 20 advanced non-small cell lung cancer patients with a median age of 68.8 years, 16 of whom were male.

Treatment:
Patients received chemotherapy with gemcitabine and carboplatin.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 leucopenia, neutropenia, and thrombocytopenia. Grade 1-2 fever and nausea/vomiting were also reported.

Results:
The median overall survival was 2.8 months.

Correspondence: Dr. Yukihiro Hasegawa; email: [email protected]



Back